DNA damage signalling guards against activated oncogenes and tumour progression
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
DNA damage response (DDR), the guardian of genomic integrity, emerges as an oncogene-inducible biological barrier against progression of cancer beyond its early stages. Recent evidence from both cell culture and animal models as well as analyses of clinical specimens show that activation of numerous oncogenes and loss of some tumour suppressors result in DNA replication stress and DNA damage that alarm the cellular DDR machinery, a multifaceted response orchestrated by the ATR-Chk1 and ATM-Chk2 kinase signalling pathways. Such activation of the DDR network leads to cellular senescence or death of oncogene-transformed cells, resulting in delay or prevention of tumorigenesis. At the same time, the ongoing chronic DDR activation creates selective pressure that eventually favours outgrowth of malignant clones with genetic or epigenetic defects in the genome maintenance machinery, such as aberrations in the ATM-Chk2-p53 cascade and other DDR components. Furthermore, the executive DDR machinery is shared by at least two anticancer barriers, as both the oncogene-induced DNA replication stress and telomere shortening impact the cell fate decisions through convergence on DNA damage signalling. In this study, we highlight recent advances in this rapidly evolving area of cancer research, with particular emphasis on mechanistic insights, emerging issues of special conceptual significance and discussion of major remaining challenges and implications of the concept of DDR as a tumorigenesi…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683 · cited 1×
“…results of poly(ADP-ribose) polymerase 1 (PARP1) inhibitors in the treatment of tumours defective in homologous recombination repair (Bryant et al., 2005; Farmer et al., 2005), additional smart strategies to exploit tumour-specific abnormalities within the DDR machinery will hopefully follow.”
BackgroundSpecific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Genome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917 · cited 1×
“Candidates for such additional events include telomere erosion, which is perceived by mammalian cells as a form of DSB (d’Adda di Fagagna et al., 2003; Takai et al., 2003), and ROS, known to be generated in cells transformed by various oncogenes and abundant in senescent cells (Mallette and…”
BackgroundCell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836 · cited 4×
“The complex cellular network that collectively forms the DNA damage response (DDR) machinery encompasses a plethora of dynamic, hierarchically ordered and mutually coordinated pathways capable of detecting the DNA lesions and signalling their presence to many DDR proteins and protein complexes that promptly repair the…”
BackgroundInfluentialDNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688 · cited 16×
“…the DDR machinery, gene knockout or inactivation of the retinoblastoma tumour suppressor (Pickering and Kowalik, 2006; Tort et al., 2006) and overexpression of several oncogenes in the RB pathway, such as E2F1 or cyclin E, did evoke the replication stress barrier (Bartkova et al., 2005a, b).”
BackgroundResultInfluentialSelf-citationATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577 · cited 2×
“While the link between defective DDR and predisposition to cancer has been known for decades (Hoeijmakers, 2001; Shiloh, 2003), and numerous components of the DDR network including p53, BRCA1 or BRCA2 (breast cancer 1 or 2), for example, qualify as tumour suppressors (Kastan and Bartek, 2004;…”
BackgroundVousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009 · cited 21×
“…stress in response to oncogenes was postulated already in the two initial studies that formulated the concept of DDR as an anticancer barrier (Gorgoulis et al., 2005; Bartkova et al., 2005a), and further support for this notion has been provided by more recent works (Bartkova et al., 2006;…”
BackgroundResultInfluentialOncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986 · cited 9×
“…a robust DDR activation in diverse cell types, including primary fibroblasts, lymphocytes and epithelial cells (Powers et al., 2004; Gorgoulis et al., 2005; Bartkova et al., 2005a, 2006; Di Micco et al., 2006; Frame et al., 2006; Pusapati et al., 2006; Reimann et al., 2007; Mallette et al., 2007).”
BackgroundMethodResultInfluentialSelf-citationOncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821 · cited 8×
“…a robust DDR activation in diverse cell types, including primary fibroblasts, lymphocytes and epithelial cells (Powers et al., 2004; Gorgoulis et al., 2005; Bartkova et al., 2005a, 2006; Di Micco et al., 2006; Frame et al., 2006; Pusapati et al., 2006; Reimann et al., 2007; Mallette et al., 2007).”
BackgroundMethodResultInfluentialDNA Damage Foci at Dysfunctional Telomeres
Takai, H., Smogorzewska, A., & de Lange, T. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00542-6 · Cited by 1,409
The common biology of cancer and ageing
Finkel, T., Serrano, M., & Blasco, M. A. (2007) · Nature · doi:10.1038/nature05985 · Cited by 988 · cited 13×
“…phenotypic hallmarks of cellular senescence, a state of permanent growth arrest Oncogene refractory to physiological proliferation stimuli, with altered cell morphology and gene expression patterns, yet with preserved metabolic activity (Campisi and d’Adda di Fagagna, 2007; Finkel et al., 2007).”
BackgroundInfluentialc-Myc Can Induce DNA Damage, Increase Reactive Oxygen Species, and Mitigate p53 Function
Vafa, O., Wade, M., Kern, S., Beeche, M., Pandita, T. K., Hampton, G. M., & Wahl, G. M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00520-8 · Cited by 876 · cited 8×
“For example, although the original report on Myc oncogeneinduced DDR employed growth factor-starved cells and concluded that the observed DNA damage occurred in non-cycling cells due to ROS (Vafa et al., 2002), the most plausible explanation of such results is that the small fraction of the myc-expressing cells that s…”
BackgroundResultInfluentialDNA damage checkpoints: from initiation to recovery or adaptation
Bartek, J., & Lukas, J. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.009 · Cited by 784 · cited 3×
“The complex cellular network that collectively forms the DNA damage response (DDR) machinery encompasses a plethora of dynamic, hierarchically ordered and mutually coordinated pathways capable of detecting the DNA lesions and signalling their presence to many DDR proteins and protein complexes that promptly repair the…”
BackgroundSelf-citationDose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis
Sarkisian, C. J., Keister, B. A., Stairs, D. B., Boxer, R. B., Moody, S. E., & Chodosh, L. A. (2007) · Nature Cell Biology · doi:10.1038/ncb1567 · Cited by 490 · cited 3×
“In this mouse model, the data suggest that a priming lesion in the form of an activating ras mutation is necessary but not sufficient to induce cellular senescence, and that also a second ‘hit’ that causes increased levels of the mutant ras is required to trigger the senescence barrier (Sarkisian et al., 2007).”
BackgroundInfluentialDiTullio, R. A., Mochan, T. A., Venere, M., Bartkova, J., Sehested, M., Bartek, J., & Halazonetis, T. D. (2002) · Nature Cell Biology · doi:10.1038/ncb892 · Cited by 407
The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence
Mallette, F. A., Gaumont-Leclerc, M.-F., & Ferbeyre, G. (2007) · Genes & Development · doi:10.1101/gad.1487307 · Cited by 406
Mammalian cell cycle checkpoints: signalling pathways and their organization in space and time
Lukas, J., Lukas, C., & Bartek, J. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.03.006 · Cited by 381
Functional links between telomeres and proteins of the DNA-damage response
d'Adda di Fagagna, F., Teo, S.-H., & Jackson, S. P. (2004) · Genes & Development · doi:10.1101/gad.1214504 · Cited by 277
The DNA damage response during DNA replication
Branzei, D., & Foiani, M. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.003 · Cited by 241
ATM promotes apoptosis and suppresses tumorigenesis in response to Myc
Pusapati, R. V., Rounbehler, R. J., Hong, S., Powers, J. T., Yan, M., Kiguchi, K., McArthur, M. J., Wong, P. K., & Johnson, D. G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507367103 · Cited by 152
E2F1 Uses the ATM Signaling Pathway to Induce p53 and Chk2 Phosphorylation and Apoptosis
Powers, J. T., Hong, S., Mayhew, C. N., Rogers, P. M., Knudsen, E. S., & Johnson, D. G. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.203.2.4 · Cited by 152
ATM Activation in Normal Human Tissues and Testicular Cancer
Bartkova, J., Bakkenist, C. J., Meyts, E. R.-D., Skakkebæk, N. E., Sehested, M., Lukas, J., Kastan, M. B., & Bartek, J. (2005) · Cell Cycle · doi:10.4161/cc.4.6.1742 · Cited by 144
Self-citationBártková, J., Hořejší, Z., Sehested, M., Nesland, J. M., Meyts, E. R., Skakkebæk, N. E., Stucki, M., Jackson, S. P., Lukáš, J., & Bártek, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210553 · Cited by 128
The DNA Damage Signaling Pathway Connects Oncogenic Stress to Cellular Senescence
Mallette, F. A., & Ferbeyre, G. (2007) · Cell Cycle · doi:10.4161/cc.6.15.4516 · Cited by 125
Rb inactivation leads to E2F1-mediated DNA double-strand break accumulation
Pickering, M. T., & Kowalik, T. F. (2006) · Oncogene · doi:10.1038/sj.onc.1209103 · Cited by 108 · cited 1×
“…tumour suppressor p16ink4a seem to be unable to activate the DDR machinery, gene knockout or inactivation of the retinoblastoma tumour suppressor (Pickering and Kowalik, 2006; Tort et al., 2006) and overexpression of several oncogenes in the RB pathway, such as E2F1 or cyclin E, did evoke the…”
BackgroundComplex engagement of DNA damage response pathways in human cancer and in lung tumor progression
Nuciforo, P. G., Luise, C., Capra, M., Pelosi, G., & d'Adda di Fagagna, F. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm108 · Cited by 80
The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo
Reimann, M., Loddenkemper, C., Rudolph, C., Schildhauer, I., Teichmann, B., Stein, H., Schlegelberger, B., Dörken, B., & Schmitt, C. A. (2007) · Blood · doi:10.1182/blood-2007-02-075614 · Cited by 78
Tort, F., Bartkova, J., Sehested, M., Ørntoft, T., Lukas, J., & Bartek, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2178 · Cited by 67
Self-citationE2F1 induces MRN foci formation and a cell cycle checkpoint response in human fibroblasts
Frame, F. M., Rogoff, H. A., Pickering, M., Cress, W. D., & Kowalik, T. F. (2006) · Oncogene · doi:10.1038/sj.onc.1209352 · Cited by 57
Bartkova, J., Rajpert‐De Meyts, E., Skakkebæk, N. E., Lukas, J., & Bartek, J. (2007) · International Journal of Andrology · doi:10.1111/j.1365-2605.2007.00772.x · Cited by 53
ATM activation is accompanied with earlier stages of prostate tumorigenesis
Fan, C., Quan, R., Feng, X., Gillis, A., He, L., Matsumoto, E. D., Salama, S., Cutz, J., Kapoor, A., & Tang, D. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.08.026 · Cited by 46
Cited by
The DNA Damage Response: Making It Safe to Play with Knives
Ciccia, A., & Elledge, S. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.019 · Cited by 4,368
“Activation of the DDR could normally prevent tumorigenesis by inducing cellular senescence or apoptosis of early tumor cells (Bartek et al., 2007).”
BackgroundInfluentialHoeijmakers, J. H. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804615 · Cited by 2,239
Matthews, H. K., Bertoli, C., & de Bruin, R. A. M. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00404-3 · Cited by 1,506
Feedback between p21 and reactive oxygen production is necessary for cell senescence
Passos, J. F., Nelson, G., Wang, C., Richter, T., Simillion, C., Proctor, C. J., Miwa, S., Olijslagers, S., Hallinan, J., Wipat, A., et al. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.5 · Cited by 1,019
“Recent interest has been spurred by mounting evidence for major roles for cellular senescence in vivo: on the one hand, oncogene-triggered senescence is a potentially very powerful tumour suppression mechanism (Ramsey and Sharpless, 2006; Bartek et al, 2007).”
Telomeres: protecting chromosomes against genome instability
O'Sullivan, R. J., & Karlseder, J. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2848 · Cited by 996
Metadata
- Authors
- Bartek, J., Bartkova, J., & Lukas, J.
- Venue
- Oncogene
- Published
- 2007-12-10
- Volume
- 26
- Issue
- 56
- Pages
- 7773-7779
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1967232610
- Cited by
- 521
- References
- 34
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 9 · 2023: 9 · 2022: 16 · 2021: 21 · 2020: 25 · 2019: 27 · 2018: 22 · 2017: 21 · 2016: 36 · 2015: 30 · 2014: 36 · 2013: 42 · 2012: 37
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- DNA damage response, oncogene activation, tumor progression, replication stress, p53, cellular senescence, tumor suppressor loss, telomere shortening, carcinogenesis, genome stability, cancer therapy resistance
- MeSH terms
- Animals, DNA Damage, DNA Repair, Humans, Neoplasms, Oncogenes, Signal Transduction, Genes, Tumor Suppressor, Cellular Senescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.